人工智能在神经肌肉疾病诊断中的应用:叙述性审查
1Pediatric Neurology, Fundación Cardio Infantil - La Cardio, Bogotá, COL.
Cureus
|November 9, 2023
概括
人工智能 (AI) 通过分析复杂的患者数据,帮助诊断神经肌肉疾病 (NMD). 人工智能应用显示出高准确度,有望在未来更早,更精确的NMD诊断.
科学领域:
- 神经学 神经学
- 医疗信息学 医疗信息学
- 生物医学工程 生物医学工程
背景情况:
- 精确诊断神经肌肉疾病 (NMD) 是一个挑战,依赖于临床评估和补充测试.
- 诊断研究数据的复杂性和数量需要先进的分析解决方案.
- 人工智能 (AI) 提供了在NMD诊断中高效数据处理和分类的潜力.
研究的目的:
- 审查人工智能应用在诊断NMD患者中的实用性.
- 综合目前关于人工智能在NMD诊断方法中的作用的研究.
主要方法:
- 对现有的AI应用到NMD诊断的文献进行叙事审查.
- 包括12项专注于人工智能的研究,用于肌肉超声波,MRI,肌电图,ALS生物标志物和遗传分析.
主要成果:
- 人工智能分类算法在大多数审查的研究中达到90%以上的准确性.
- 人工智能在分析各种数据类型,包括成像和遗传信息方面表现出有效性.
- 具体应用包括肌肉超声波,MRI,肌电图和NMD的生物标志物分析.
结论:
- 人工智能应用程序是NMD诊断中对患者信息进行分类和合成的宝贵工具.
- 预计更精确的人工智能算法的开发将大大改善NMD早期检测.
- 人工智能有望提高诊断神经肌肉疾病的准确性和及时性.
相关概念视频
Myasthenia Gravis: Diagnostic Tests
914
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
914
Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K


